Minor groove binder antibody conjugates employing a water soluble β-glucuronide linker
The minor groove binder β-glucuronide drug-linker 3 was constructed from amino CBI 1 and determined to be a substrate for Escherichia coli β-glucuronidase (EC 3.2.1.31), resulting in facile drug release. Compound 3 was conjugated to mAbs cAC10 (anti-CD30) and h1F6 (anti-CD70) to give antibody-drug c...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters Vol. 17; no. 8; pp. 2278 - 2280 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Oxford
Elsevier Ltd
15-04-2007
Elsevier |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The minor groove binder β-glucuronide drug-linker
3 was constructed from amino CBI
1 and determined to be a substrate for
Escherichia coli β-glucuronidase (EC 3.2.1.31), resulting in facile drug release. Compound
3 was conjugated to mAbs cAC10 (anti-CD30) and h1F6 (anti-CD70) to give antibody-drug conjugates (ADCs) with potencies comparable to that of free drug
1. The ADCs were largely monomeric at intermediate loading levels (4–5
drug/mAb), in contrast to highly aggregated
p-aminobenzylcarbamate dipeptide-based ADCs of
1 previously reported. Significant levels of immunologic specificity were observed with cAC10-
3 by comparing antigen positive versus negative cell lines and binding versus non-binding control ADCs. The water soluble β-glucuronide linker is stable in plasma and effectively delivers drugs to target cells leading to potent cytotoxic activities. |
---|---|
AbstractList | The minor groove binder β-glucuronide drug-linker
3 was constructed from amino CBI
1 and determined to be a substrate for
Escherichia coli β-glucuronidase (EC 3.2.1.31), resulting in facile drug release. Compound
3 was conjugated to mAbs cAC10 (anti-CD30) and h1F6 (anti-CD70) to give antibody-drug conjugates (ADCs) with potencies comparable to that of free drug
1. The ADCs were largely monomeric at intermediate loading levels (4–5
drug/mAb), in contrast to highly aggregated
p-aminobenzylcarbamate dipeptide-based ADCs of
1 previously reported. Significant levels of immunologic specificity were observed with cAC10-
3 by comparing antigen positive versus negative cell lines and binding versus non-binding control ADCs. The water soluble β-glucuronide linker is stable in plasma and effectively delivers drugs to target cells leading to potent cytotoxic activities. The minor groove binder beta -glucuronide drug-linker 3 was constructed from amino CBI 1 and determined to be a substrate for Escherichia coli beta -glucuronidase (EC 3.2.1.31), resulting in facile drug release. Compound 3 was conjugated to mAbs cAC10 (anti-CD30) and h1F6 (anti-CD70) to give antibody-drug conjugates (ADCs) with potencies comparable to that of free drug 1. The ADCs were largely monomeric at intermediate loading levels (4-5 drug/mAb), in contrast to highly aggregated p-aminobenzylcarbamate dipeptide-based ADCs of 1 previously reported. Significant levels of immunologic specificity were observed with cAC10- 3 by comparing antigen positive versus negative cell lines and binding versus non-binding control ADCs. The water soluble beta -glucuronide linker is stable in plasma and effectively delivers drugs to target cells leading to potent cytotoxic activities. The minor groove binder beta-glucuronide drug-linker 3 was constructed from amino CBI 1 and determined to be a substrate for Escherichia coli beta-glucuronidase (EC 3.2.1.31), resulting in facile drug release. Compound 3 was conjugated to mAbs cAC10 (anti-CD30) and h1F6 (anti-CD70) to give antibody-drug conjugates (ADCs) with potencies comparable to that of free drug 1. The ADCs were largely monomeric at intermediate loading levels (4-5drug/mAb), in contrast to highly aggregated p-aminobenzylcarbamate dipeptide-based ADCs of 1 previously reported. Significant levels of immunologic specificity were observed with cAC10-3 by comparing antigen positive versus negative cell lines and binding versus non-binding control ADCs. The water soluble beta-glucuronide linker is stable in plasma and effectively delivers drugs to target cells leading to potent cytotoxic activities. |
Author | Meyer, Damon L. Jeffrey, Scott C. Senter, Peter D. Moser, Ruth F. Nguyen, Minh T. Miyamoto, Jamie B. |
Author_xml | – sequence: 1 givenname: Scott C. surname: Jeffrey fullname: Jeffrey, Scott C. email: sjeffrey@seagen.com – sequence: 2 givenname: Minh T. surname: Nguyen fullname: Nguyen, Minh T. – sequence: 3 givenname: Ruth F. surname: Moser fullname: Moser, Ruth F. – sequence: 4 givenname: Damon L. surname: Meyer fullname: Meyer, Damon L. – sequence: 5 givenname: Jamie B. surname: Miyamoto fullname: Miyamoto, Jamie B. – sequence: 6 givenname: Peter D. surname: Senter fullname: Senter, Peter D. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18658327$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17293111$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kMFu1DAQhi1URLeFF-CAfIFbgidx7FjigiooSEVcQHCzHHuy8uLYi50U7WvxIDxTs9qVeuM00uj7f818V-QipoiEvARWAwPxdlcPkw11w5isGdRMwhOyAS541XLWXZANU4JVveI_L8lVKTvGgDPOn5FLkI1qAWBDfnzxMWW6zSndIx18dJipibMfkjtQm-Ju2ZoZC8VpH9LBxy019M-6ybSksAwB6b-_1TYsdskpeoc0-PgL83PydDSh4IvzvCbfP374dvOpuvt6-_nm_V1lOXRz1fai6zonQSqhlEQje8lbtJyjEdwNxlqUApwS0PRj0ze2VaPAQQ2mx1HJ9pq8OfXuc_q9YJn15IvFEEzEtBQNSiopFV_B5gTanErJOOp99pPJBw1MH3XqnT7q1EedmoFeda6hV-f2ZZjQPUbO_lbg9RkwxZowZhOtL4_c-l7fNscz3504XF3ce8y6WI_RovMZ7axd8v-74wFfj5bI |
CitedBy_id | crossref_primary_10_1111_cbdd_12085 crossref_primary_10_3390_toxins3070848 crossref_primary_10_1021_bc9001097 crossref_primary_10_1002_biot_201200250 crossref_primary_10_1002_cmdc_201100114 crossref_primary_10_1158_1535_7163_MCT_14_0212 crossref_primary_10_1038_s41392_022_00947_7 crossref_primary_10_3390_ijms17040561 crossref_primary_10_1097_PPO_0b013e318172d704 crossref_primary_10_1021_ml100039h crossref_primary_10_1021_mp500781a crossref_primary_10_4155_tde_14_63 crossref_primary_10_1021_acs_bioconjchem_3c00363 crossref_primary_10_3816_CLM_2009_n_024 crossref_primary_10_1158_1535_7163_MCT_16_0343 crossref_primary_10_1177_2472555220912955 crossref_primary_10_4062_biomolther_2015_116 crossref_primary_10_3390_biomedicines12030500 crossref_primary_10_3390_biomedicines9080872 crossref_primary_10_1021_acs_jmedchem_7b00563 crossref_primary_10_1158_1535_7163_MCT_14_0040_T crossref_primary_10_3390_ijms161023784 crossref_primary_10_1016_j_ejmech_2017_08_008 crossref_primary_10_1158_1535_7163_MCT_16_0641 crossref_primary_10_1080_00914037_2015_1038818 crossref_primary_10_1002_jhet_591 crossref_primary_10_1016_j_bmc_2017_04_010 crossref_primary_10_1039_D1CC00957E crossref_primary_10_1016_j_drup_2014_11_001 crossref_primary_10_1016_j_bmcl_2022_128953 crossref_primary_10_3390_ph14050442 crossref_primary_10_1186_s40164_024_00493_8 crossref_primary_10_1158_1535_7163_MCT_16_0038 crossref_primary_10_1007_s00280_012_1925_8 crossref_primary_10_1021_bc800289a crossref_primary_10_1021_bc9002019 crossref_primary_10_3923_ijp_2017_785_807 |
Cites_doi | 10.1002/ijc.10207 10.1021/jm990136b 10.1097/01.ju.0000158121.49085.ba 10.1038/nbt832 10.1016/S0968-0896(00)82007-6 10.1021/bc0600214 10.1016/S0960-894X(01)00707-7 10.1021/jo0263115 10.1016/S0968-0896(00)00157-7 10.1021/jm040137q 10.1200/JCO.2000.18.11.2282 10.1097/00000478-200005000-00014 10.1248/cpb.43.378 10.1021/bc025536j 10.1021/bc0502917 10.1038/nbt1141 10.4049/jimmunol.159.10.4959 10.1021/bc050201y 10.1124/jpet.103.060533 |
ContentType | Journal Article |
Copyright | 2007 Elsevier Ltd 2007 INIST-CNRS |
Copyright_xml | – notice: 2007 Elsevier Ltd – notice: 2007 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7QO 8FD C1K FR3 P64 |
DOI | 10.1016/j.bmcl.2007.01.071 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Engineering Research Database Biotechnology Research Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | Engineering Research Database MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Chemistry |
EISSN | 1464-3405 |
EndPage | 2280 |
ExternalDocumentID | 10_1016_j_bmcl_2007_01_071 17293111 18658327 S0960894X07001217 |
Genre | Journal Article |
GroupedDBID | --- --K --M .HR .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5VS 6TJ 7-5 71M 8P~ 9JM 9JN AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARLI AATCM AAXUO ABBQC ABFNM ABGSF ABJNI ABLVK ABMAC ABMZM ABTAH ABUDA ABXDB ABYKQ ABZDS ACDAQ ACGFS ACIUM ACNNM ACRLP ADBBV ADECG ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AFZHZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 D0L DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FLBIZ FNPLU FYGXN G-2 G-Q GBLVA HEA HMK HMO HMS HMT HVGLF HZ~ IHE J1W KOM LCYCR LZ2 M29 M2Z M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCB SCC SDF SDG SDP SES SEW SOC SPC SPCBC SPT SSH SSK SSP SSU SSZ T5K WUQ XFK XPP Y6R YK3 ZMT ZY4 ~02 ~G- ABPIF ABPTK IQODW AAXKI AKRWK CGR CUY CVF ECM EIF NPM AAYXX AFJKZ CITATION 7QL 7QO 8FD C1K FR3 P64 |
ID | FETCH-LOGICAL-c415t-386555d71796997ea78743ec44ea64dbacce761d96128f282c39f6eb9ba8ef973 |
ISSN | 0960-894X |
IngestDate | Fri Oct 25 23:56:46 EDT 2024 Thu Sep 26 16:09:25 EDT 2024 Sat Sep 28 07:55:49 EDT 2024 Sun Oct 22 16:06:44 EDT 2023 Fri Feb 23 02:27:55 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Drug β-Glucuronidase Conjugate Antibody Drug-linker h1F6 Linker Aggregation Minor groove binder Targeted Anti-CD30 cAC10 Delivery Monoclonal β-Glucuronide Release Anti-CD70 Cancer Spacer arm hlF6 Escherichia coli Cytotoxicity Monoclonal antibody Organic carbamate Glucuroconjugate Lymphoproliferative syndrome Bacteria Chemical synthesis Tumor cell Enterobacteriaceae Minor groove Enzyme Hodgkin disease Malignant hemopathy In vitro Lymphoma Biological activity Substrate Water soluble compound Cell line Glycosidases Uronic acid Hydrolases Conjugated compound O-Glycosidases |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c415t-386555d71796997ea78743ec44ea64dbacce761d96128f282c39f6eb9ba8ef973 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 17293111 |
PQID | 19797794 |
PQPubID | 23462 |
PageCount | 3 |
ParticipantIDs | proquest_miscellaneous_19797794 crossref_primary_10_1016_j_bmcl_2007_01_071 pubmed_primary_17293111 pascalfrancis_primary_18658327 elsevier_sciencedirect_doi_10_1016_j_bmcl_2007_01_071 |
PublicationCentury | 2000 |
PublicationDate | 2007-04-15 |
PublicationDateYYYYMMDD | 2007-04-15 |
PublicationDate_xml | – month: 04 year: 2007 text: 2007-04-15 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | Oxford |
PublicationPlace_xml | – name: Oxford – name: England |
PublicationTitle | Bioorganic & medicinal chemistry letters |
PublicationTitleAlternate | Bioorg Med Chem Lett |
PublicationYear | 2007 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Yasuzawa, Muroi, Ichimura, Takahashi, Ogawa, Takahashi, Sano, Saitoh (bib3) 1995; 43 Atwell, Milbank, Wilson, Hogg, Denny (bib6) 1999; 42 Boger, Johnson, Yun, Tarby (bib5) 1994; 2 Jeffrey, Torgov, Andreyka, Boddington, Cerveny, Denny, Gordon, Gustin, Haugen, Kline, Nguyen, Senter (bib7) 2005; 48 Wahl, Klussman, Thompson, Chen, Francisco, Risdon, Chace, Siegall, Francisco (bib11) 2002; 62 Dubowchik, Firestone, Padilla, Willner, Hofstead, Mosure, Knipe, Lasch, Trail (bib21) 2002; 13 Walker, Dubowchik, Hofstead, Trail, Firestone (bib22) 2002; 12 Wu, Senter (bib20) 2005; 23 Liang, B. S. C.; Sanjeev, G.; Vincent, G.; Killian, H.; Li, Z. -H.; Bidal, S. In Yang, Denny (bib10) 2002; 67 Tesselaar, Gravestein, van Schijndel, Borst, van Lier (bib16) 1997; 159 Junker, Hindermann, von Eggeling, Diegmann, Haessler, Schubert (bib12) 2005; 173 Suzawa, Nagamura, Saito, Ohta, Hanai, Yamasaki (bib9) 2000; 8 Sun, Beam, Cerveny, Hamblett, Blackmore, Torgov, Handley, Ihle, Senter, Alley (bib17) 2005; 16 Xie, Audette, Hoffee, Lambert, Blattler (bib24) 2004; 308 Held-Feindt, Mentlein (bib14) 2002; 98 Diegmann, Junker, Gerstmayer, Bosio, Hindermann, Rosenhahn, von Eggeling (bib15) 2005 Jeffrey, Andreyka, Bernhardt, Kissler, Kline, Lenox, Moser, Nguyen, Okeley, Stone, Zhang, Senter (bib1) 2006; 17 Hishima, Fukayama, Hayashi, Fujii, Ooba, Funata, Koike (bib13) 2000; 24 Medarex, Inc: USA, 2005; pp 222. Doronina, Mendelsohn, Bovee, Cerveny, Alley, Meyer, Oflazoglu, Toki, Sanderson, Zabinski, Wahl, Senter (bib18) 2006; 17 Doronina, Toki, Torgov, Mendelsohn, Cerveny, Chace, DeBlanc, Gearing, Bovee, Siegall, Francisco, Wahl, Meyer, Senter (bib19) 2003; 21 Saleh, Sugarman, Murray, Ostroff, Healey, Jones, Daniel, LeBherz, Brewer, Onetto, LoBuglio (bib23) 2000; 18 Desbene, Van, Michel, Koch, Tillequin, Fournier, Farjaudon, Monneret (bib2) 1998; 13 Nagamura, Saito (bib4) 1998; 387 Yasuzawa (10.1016/j.bmcl.2007.01.071_bib3) 1995; 43 Dubowchik (10.1016/j.bmcl.2007.01.071_bib21) 2002; 13 Hishima (10.1016/j.bmcl.2007.01.071_bib13) 2000; 24 Jeffrey (10.1016/j.bmcl.2007.01.071_bib1) 2006; 17 Yang (10.1016/j.bmcl.2007.01.071_bib10) 2002; 67 Sun (10.1016/j.bmcl.2007.01.071_bib17) 2005; 16 Wahl (10.1016/j.bmcl.2007.01.071_bib11) 2002; 62 Desbene (10.1016/j.bmcl.2007.01.071_bib2) 1998; 13 Atwell (10.1016/j.bmcl.2007.01.071_bib6) 1999; 42 Doronina (10.1016/j.bmcl.2007.01.071_bib19) 2003; 21 Nagamura (10.1016/j.bmcl.2007.01.071_bib4) 1998; 387 Junker (10.1016/j.bmcl.2007.01.071_bib12) 2005; 173 Boger (10.1016/j.bmcl.2007.01.071_bib5) 1994; 2 Suzawa (10.1016/j.bmcl.2007.01.071_bib9) 2000; 8 Held-Feindt (10.1016/j.bmcl.2007.01.071_bib14) 2002; 98 Tesselaar (10.1016/j.bmcl.2007.01.071_bib16) 1997; 159 Xie (10.1016/j.bmcl.2007.01.071_bib24) 2004; 308 Wu (10.1016/j.bmcl.2007.01.071_bib20) 2005; 23 Doronina (10.1016/j.bmcl.2007.01.071_bib18) 2006; 17 Jeffrey (10.1016/j.bmcl.2007.01.071_bib7) 2005; 48 Walker (10.1016/j.bmcl.2007.01.071_bib22) 2002; 12 10.1016/j.bmcl.2007.01.071_bib8 Diegmann (10.1016/j.bmcl.2007.01.071_bib15) 2005 Saleh (10.1016/j.bmcl.2007.01.071_bib23) 2000; 18 |
References_xml | – volume: 173 start-page: 2150 year: 2005 ident: bib12 publication-title: J. Urol. contributor: fullname: Schubert – volume: 159 start-page: 4959 year: 1997 ident: bib16 publication-title: J. Immunol. contributor: fullname: van Lier – volume: 12 start-page: 217 year: 2002 ident: bib22 publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Firestone – volume: 43 start-page: 378 year: 1995 ident: bib3 publication-title: Chem. Pharm. Bull. (Tokyo) contributor: fullname: Saitoh – volume: 16 start-page: 1282 year: 2005 ident: bib17 publication-title: Bioconjug. Chem. contributor: fullname: Alley – volume: 24 start-page: 742 year: 2000 ident: bib13 publication-title: Am. J. Surg. Pathol. contributor: fullname: Koike – volume: 98 start-page: 352 year: 2002 ident: bib14 publication-title: Int. J. Cancer contributor: fullname: Mentlein – volume: 67 start-page: 8958 year: 2002 ident: bib10 publication-title: J. Org. Chem. contributor: fullname: Denny – volume: 23 start-page: 1137 year: 2005 ident: bib20 publication-title: Nat. Biotechnol. contributor: fullname: Senter – volume: 62 start-page: 3736 year: 2002 ident: bib11 publication-title: Cancer Res. contributor: fullname: Francisco – volume: 308 start-page: 1073 year: 2004 ident: bib24 publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Blattler – year: 2005 ident: bib15 publication-title: Eur. J. Cancer contributor: fullname: von Eggeling – volume: 13 start-page: 955 year: 1998 ident: bib2 publication-title: Anticancer Drug Des. contributor: fullname: Monneret – volume: 387 start-page: 1636 year: 1998 ident: bib4 publication-title: Chem. Heterocycl. Comp. contributor: fullname: Saito – volume: 48 start-page: 1344 year: 2005 ident: bib7 publication-title: J. Med. Chem. contributor: fullname: Senter – volume: 18 start-page: 2282 year: 2000 ident: bib23 publication-title: J. Clin. Oncol. contributor: fullname: LoBuglio – volume: 21 start-page: 778 year: 2003 ident: bib19 publication-title: Nat. Biotechnol. contributor: fullname: Senter – volume: 2 start-page: 115 year: 1994 ident: bib5 publication-title: Bioorg. Med. Chem. contributor: fullname: Tarby – volume: 42 start-page: 3400 year: 1999 ident: bib6 publication-title: J. Med. Chem. contributor: fullname: Denny – volume: 17 start-page: 831 year: 2006 ident: bib1 publication-title: Bioconjug. Chem. contributor: fullname: Senter – volume: 13 start-page: 855 year: 2002 ident: bib21 publication-title: Bioconjug. Chem. contributor: fullname: Trail – volume: 17 start-page: 114 year: 2006 ident: bib18 publication-title: Bioconjug. Chem. contributor: fullname: Senter – volume: 8 start-page: 2175 year: 2000 ident: bib9 publication-title: Bioorg. Med. Chem. contributor: fullname: Yamasaki – volume: 98 start-page: 352 year: 2002 ident: 10.1016/j.bmcl.2007.01.071_bib14 publication-title: Int. J. Cancer doi: 10.1002/ijc.10207 contributor: fullname: Held-Feindt – volume: 42 start-page: 3400 year: 1999 ident: 10.1016/j.bmcl.2007.01.071_bib6 publication-title: J. Med. Chem. doi: 10.1021/jm990136b contributor: fullname: Atwell – volume: 173 start-page: 2150 year: 2005 ident: 10.1016/j.bmcl.2007.01.071_bib12 publication-title: J. Urol. doi: 10.1097/01.ju.0000158121.49085.ba contributor: fullname: Junker – ident: 10.1016/j.bmcl.2007.01.071_bib8 – volume: 21 start-page: 778 year: 2003 ident: 10.1016/j.bmcl.2007.01.071_bib19 publication-title: Nat. Biotechnol. doi: 10.1038/nbt832 contributor: fullname: Doronina – volume: 13 start-page: 955 year: 1998 ident: 10.1016/j.bmcl.2007.01.071_bib2 publication-title: Anticancer Drug Des. contributor: fullname: Desbene – volume: 2 start-page: 115 year: 1994 ident: 10.1016/j.bmcl.2007.01.071_bib5 publication-title: Bioorg. Med. Chem. doi: 10.1016/S0968-0896(00)82007-6 contributor: fullname: Boger – volume: 17 start-page: 831 year: 2006 ident: 10.1016/j.bmcl.2007.01.071_bib1 publication-title: Bioconjug. Chem. doi: 10.1021/bc0600214 contributor: fullname: Jeffrey – volume: 12 start-page: 217 year: 2002 ident: 10.1016/j.bmcl.2007.01.071_bib22 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/S0960-894X(01)00707-7 contributor: fullname: Walker – volume: 67 start-page: 8958 year: 2002 ident: 10.1016/j.bmcl.2007.01.071_bib10 publication-title: J. Org. Chem. doi: 10.1021/jo0263115 contributor: fullname: Yang – volume: 387 start-page: 1636 year: 1998 ident: 10.1016/j.bmcl.2007.01.071_bib4 publication-title: Chem. Heterocycl. Comp. contributor: fullname: Nagamura – volume: 8 start-page: 2175 year: 2000 ident: 10.1016/j.bmcl.2007.01.071_bib9 publication-title: Bioorg. Med. Chem. doi: 10.1016/S0968-0896(00)00157-7 contributor: fullname: Suzawa – year: 2005 ident: 10.1016/j.bmcl.2007.01.071_bib15 publication-title: Eur. J. Cancer contributor: fullname: Diegmann – volume: 48 start-page: 1344 year: 2005 ident: 10.1016/j.bmcl.2007.01.071_bib7 publication-title: J. Med. Chem. doi: 10.1021/jm040137q contributor: fullname: Jeffrey – volume: 18 start-page: 2282 year: 2000 ident: 10.1016/j.bmcl.2007.01.071_bib23 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2000.18.11.2282 contributor: fullname: Saleh – volume: 24 start-page: 742 year: 2000 ident: 10.1016/j.bmcl.2007.01.071_bib13 publication-title: Am. J. Surg. Pathol. doi: 10.1097/00000478-200005000-00014 contributor: fullname: Hishima – volume: 43 start-page: 378 year: 1995 ident: 10.1016/j.bmcl.2007.01.071_bib3 publication-title: Chem. Pharm. Bull. (Tokyo) doi: 10.1248/cpb.43.378 contributor: fullname: Yasuzawa – volume: 13 start-page: 855 year: 2002 ident: 10.1016/j.bmcl.2007.01.071_bib21 publication-title: Bioconjug. Chem. doi: 10.1021/bc025536j contributor: fullname: Dubowchik – volume: 17 start-page: 114 year: 2006 ident: 10.1016/j.bmcl.2007.01.071_bib18 publication-title: Bioconjug. Chem. doi: 10.1021/bc0502917 contributor: fullname: Doronina – volume: 23 start-page: 1137 year: 2005 ident: 10.1016/j.bmcl.2007.01.071_bib20 publication-title: Nat. Biotechnol. doi: 10.1038/nbt1141 contributor: fullname: Wu – volume: 159 start-page: 4959 year: 1997 ident: 10.1016/j.bmcl.2007.01.071_bib16 publication-title: J. Immunol. doi: 10.4049/jimmunol.159.10.4959 contributor: fullname: Tesselaar – volume: 62 start-page: 3736 year: 2002 ident: 10.1016/j.bmcl.2007.01.071_bib11 publication-title: Cancer Res. contributor: fullname: Wahl – volume: 16 start-page: 1282 year: 2005 ident: 10.1016/j.bmcl.2007.01.071_bib17 publication-title: Bioconjug. Chem. doi: 10.1021/bc050201y contributor: fullname: Sun – volume: 308 start-page: 1073 year: 2004 ident: 10.1016/j.bmcl.2007.01.071_bib24 publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.103.060533 contributor: fullname: Xie |
SSID | ssj0014044 |
Score | 2.1040397 |
Snippet | The minor groove binder β-glucuronide drug-linker
3 was constructed from amino CBI
1 and determined to be a substrate for
Escherichia coli β-glucuronidase (EC... The minor groove binder beta-glucuronide drug-linker 3 was constructed from amino CBI 1 and determined to be a substrate for Escherichia coli... The minor groove binder beta -glucuronide drug-linker 3 was constructed from amino CBI 1 and determined to be a substrate for Escherichia coli beta... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2278 |
SubjectTerms | Aggregation Anti-CD30 Anti-CD70 Antibodies, Monoclonal - therapeutic use Antibody Antigens, Neoplasm - immunology Antineoplastic Agents, Alkylating - chemical synthesis Antineoplastic Agents, Alkylating - pharmacokinetics Biological and medical sciences cAC10 Cancer Cell Line, Tumor Cell Survival - drug effects Conjugate Cross-Linking Reagents Delivery Drug Drug Delivery Systems - methods Drug-linker Escherichia coli Glucuronates - chemistry Glucuronidase - metabolism h1F6 Humans Immunoconjugates - chemistry Immunoconjugates - metabolism Immunoconjugates - therapeutic use Inhibitory Concentration 50 Linker Medical sciences Minor groove binder Miscellaneous Monoclonal Pharmacology. Drug treatments Prodrugs - chemical synthesis Prodrugs - metabolism Prodrugs - pharmacokinetics Release Solubility Targeted β-Glucuronidase β-Glucuronide |
Title | Minor groove binder antibody conjugates employing a water soluble β-glucuronide linker |
URI | https://dx.doi.org/10.1016/j.bmcl.2007.01.071 https://www.ncbi.nlm.nih.gov/pubmed/17293111 https://search.proquest.com/docview/19797794 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6lrQRICEHKIzzKHigXy5EfG-_uMaSpCiJcGkRv1nq9aRO1dtXEQvlb_BB-E7MP2wmiCJC4ONFGjteezzuzM9_MIPRGUsHjPJiB5cYynyQgCyaZ8qMslESBwSsMGfPklH46Y0djMu506r6D7dh_lTSMgax15uxfSLv5UxiA7yBzOILU4fhHcp_Mi_LGOweDWNPSdTFEzZJczbMyX2uO-aLSjrOlp0yrX5Oi6H0VulSinpfOozocjQ_fRYbMXunKubnydJjX0XjrAPC8tA2hpAGPC9HrYiN1Bznv0mQKbVAUTc6YcbeaghCjfuOJPq_WyrH4iwtv2vwwKZeuN3O1uvCO23G1tuNHulmS97G_5bygOg5j0zetR63OqmkpTMY1mQQ-45a52Vd2YSYJ8WMSDLZWbrqBULa5DEe2L5BT6brkzy_VhfVcLPrZlbx05SxDXbKxVY4NZfFUz0pPKqCmDh7dQXsRLG6wtu4N34_PPjSxKxKYFsLNXbhULcsq_PlKt5lD96_FEl7Sme2ucvv2x5hB04fogdu_4KEF3iPUUUUX7Q8LsSqv1vgtNoxiE6rporujGgtddGfiSBz76IuBKLYQxRaiuIYobiGKG4higQ1EsYMo_v5tE57YwvMx-nw8no5OfNffw5dgNq583W52MMgp6ISEc6oEKA8SK0mIEgnJMyGlokmYc7DC2SxikYz5LFEZzwRTM07jJ2i3KAv1DOEwj2nGKVMRkyTKAxGImCf6kzCRcNlDXv2Y02tbxiWt-Y2LVAtF92OlaRCmIJQeGtSSSJ0hag3MFIDz2_MOtsTWXgruFFQn7aHXtRxTeP46NicKVVbLNOQUdmKc9NBTK972XNj-xmCRPP_HSb1A99o37yXaXd1U6hXaWebVgUPuD-NIyfY |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Minor+groove+binder+antibody+conjugates+employing+a+water+soluble+%CE%B2-glucuronide+linker&rft.jtitle=Bioorganic+%26+medicinal+chemistry+letters&rft.au=Jeffrey%2C+Scott+C.&rft.au=Nguyen%2C+Minh+T.&rft.au=Moser%2C+Ruth+F.&rft.au=Meyer%2C+Damon+L.&rft.date=2007-04-15&rft.pub=Elsevier+Ltd&rft.issn=0960-894X&rft.eissn=1464-3405&rft.volume=17&rft.issue=8&rft.spage=2278&rft.epage=2280&rft_id=info:doi/10.1016%2Fj.bmcl.2007.01.071&rft.externalDocID=S0960894X07001217 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-894X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-894X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-894X&client=summon |